help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pao, C. S.
Right arrow Articles by McKenzie, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pao, C. S.
Right arrow Articles by McKenzie, S. A.
American Journal of Respiratory and Critical Care Medicine Vol 166. pp. 945-949, (2002)
© 2002 American Thoracic Society


Original Articles

Randomized Controlled Trial of Fluticasone in Preschool Children with Intermittent Wheeze

Caroline S. Pao and Sheila A. McKenzie

Department of Respiratory Paediatrics, The Royal London Hospital, Whitechapel, London, United Kingdom

Correspondence and requests for reprints should be addressed to Sheila A. McKenzie, M.D., Department of Respiratory Paediatrics, Fielden House, The Royal London Hospital, Whitechapel, London E1 1BB, United Kingdom. E-mail: s.a.mckenzie{at}qmul.ac.uk

Preschool children with intermittent wheeze are often prescribed inhaled corticosteroids, although there is no proven benefit. Measurement of airway resistance by the interrupter technique can be used to objectively assess response to treatment. If lung function improves, treatment may be justified. Children with intermittent wheeze aged 2 to <= 5 years of age completed a 6-week randomized controlled crossover trial of fluticasone propionate (100 µg, twice daily), followed by a 10-week parallel extension. The relationships between changes in resistance, serum immunoglobulin E and sensitization measured by skin prick testing were investigated. Sixty-one children completed the crossover trial and 44 (72%) completed the extension. After 6 weeks, geometric mean change in resistance was -16.0% (95% confidence interval, -7.0 to -25.0%, p = 0.003) in sensitized children and -3.5% (95% confidence interval, +0.7 to -7.6%, p = 0.1) in nonsensitized children. Changes in resistance were unrelated to immunoglobulin E. Sixteen weeks after stopping fluticasone, resistance returned to baseline. This is the first study of preschool children with intermittent wheeze that has related changes in lung function on treatment to aeroallergen sensitization. Lung function improved in sensitized children and deteriorated after stopping treatment. Treatment with inhaled steroids may be justified in sensitized children.

Key Words: asthma • child, preschool • airway resistance • skin test




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
H. K. Reddel, D. R. Taylor, E. D. Bateman, L.-P. Boulet, H. A. Boushey, W. W. Busse, T. B. Casale, P. Chanez, P. L. Enright, P. G. Gibson, et al.
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice
Am. J. Respir. Crit. Care Med., July 1, 2009; 180(1): 59 - 99.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
A S Pelkonen, K Malmstrom, L P Malmberg, S Sarna, M Turpeinen, M Kajosaari, T Haahtela, and M J Makela
Budesonide improves decreased airway conductance in infants with respiratory symptoms
Arch. Dis. Child., July 1, 2009; 94(7): 536 - 541.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. A. Castro-Rodriguez and G. J. Rodrigo
Efficacy of Inhaled Corticosteroids in Infants and Preschoolers With Recurrent Wheezing and Asthma: A Systematic Review With Meta-analysis
Pediatrics, March 1, 2009; 123(3): e519 - e525.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
F. M. Ducharme, C. Lemire, F. J.D. Noya, G. M. Davis, N. Alos, H. Leblond, C. Savdie, J.-P. Collet, L. Khomenko, G. Rivard, et al.
Preemptive Use of High-Dose Fluticasone for Virus-Induced Wheezing in Young Children
N. Engl. J. Med., January 22, 2009; 360(4): 339 - 353.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. Beydon, S. D. Davis, E. Lombardi, J. L. Allen, H. G. M. Arets, P. Aurora, H. Bisgaard, G. M. Davis, F. M. Ducharme, H. Eigen, et al.
An Official American Thoracic Society/European Respiratory Society Statement: Pulmonary Function Testing in Preschool Children
Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1304 - 1345.
[Full Text] [PDF]


Home page
NEJMHome page
T. W. Guilbert, W. J. Morgan, R. S. Zeiger, D. T. Mauger, S. J. Boehmer, S. J. Szefler, L. B. Bacharier, R. F. Lemanske Jr., R. C. Strunk, D. B. Allen, et al.
Long-term inhaled corticosteroids in preschool children at high risk for asthma.
N. Engl. J. Med., May 11, 2006; 354(19): 1985 - 1997.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
Pharmacotherapy -- treatment of intermittent asthma with ICSs
Can. Med. Assoc. J., September 13, 2005; 173(6_suppl): S33 - S36.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. M. Teper, C. D. Kofman, G. A. Szulman, S. M. Vidaurreta, and A. F. Maffey
Fluticasone Improves Pulmonary Function in Children under 2 Years Old with Risk Factors for Asthma
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 587 - 590.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
I Dundas, S A McKenzie, E Lombardi, and P D Sly
Interrupter resistance
Thorax, May 1, 2004; 59(5): 449 - 450.
[Full Text] [PDF]


Home page
ThoraxHome page
E Y Chan, P D Bridge, I Dundas, C S Pao, M J R Healy, and S A McKenzie
Repeatability of airway resistance measurements made using the interrupter technique
Thorax, April 1, 2003; 58(4): 344 - 347.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 333 - 344.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society
  ATS Clinical Skills Tests